FUS and hepatocellular carcinoma: Our work elucidated that LINC00659 inhibited HCC progression and aerobic glycolysis via the FUS/SLC10A1 axis, revealing a novel lncRNA–RNA-binding protein–mRNA network in HCC, which might provide potential therapeutic targets for HCC.